Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors.

@article{Lundberg2001VasoactiveIP,
  title={Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors.},
  author={Pernilla Lundberg and Inger Lundgren and Hitoshi Mukohyama and Petri Lehenkari and M A Horton and Ulf H. Lerner},
  journal={Endocrinology},
  year={2001},
  volume={142 1},
  pages={339-47}
}
Three distinct complementary DNAs for vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP) receptors have been cloned and designated VIP-1 receptor (VIP-1R), VIP-2 receptor (VIP-2R), and PACAP receptor (PACAP-R). In the present study, we have characterized the binding sites on primary mouse calvarial osteoblasts for VIP and related peptides. By analyzing the cAMP response, the rank order of response observed was PACAP 38 > PACAP 27 > helodermin > VIP… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology • 2008
View 4 Excerpts
Highly Influenced

Crosstalk between the brain and bone.

Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases • 2012
View 1 Excerpt

Similar Papers

Loading similar papers…